An interventional study of transcranial direct current stimulation in Chronic Pain and Aging, sponsored by Université de Sherbrooke. Recruiting at 2 sites in Canada. Open to participants aged 56 Years and older. Per ClinicalTrials.gov, last updated 2023-07-12.
Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Chronic Pain by Université de Sherbrooke — 8 open to participants now, 9 under way, none of them phase 3. Chronic Pain · Université de Sherbrooke.
Among the 15 studies in Chronic Pain by Université de Sherbrooke, this one is the 8th largest by planned enrollment of the 11 interventional ones that give a count, is one of 4 that started in 2022, is one of 10 with no phase, and was the 11th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →8 of the 15 studies in Chronic Pain by Université de Sherbrooke are open now, in 1 country. Recruiting first, the newest first:
Université de Sherbrooke · Sites in Canada
Ages 18+
Université de Sherbrooke · Sites in Canada
Ages 65+
Université de Sherbrooke · Sites in Canada
Ages 55+
Université de Sherbrooke · Sites in Canada
Ages 18+
Université de Sherbrooke · Sites in Canada
Ages 60+
By country, each count listing its studies:
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 56 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 4 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 24 is below the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 32 across the 11 interventional studies, 137 across the 4 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Université de Sherbrooke is the lead sponsor of 298 studies on the registry; 67 are open to participants now.
1 of the studies in Chronic Pain by Université de Sherbrooke that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07137845Université de SherbrookeVirtual Reality and Cranial Nerve Non-invasive Neuromodulation to Improve Quality of Life for Veterans | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Chronic Pain by Université de Sherbrooke, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Chronic pain is one of the main factors influencing workers' retention at work. Considering that the prevalence of suffering from chronic pain increases with age, older workers are most likely to be absent from work because of their pain.
Transcranial direct current stimulation (tDCS) is a treatment option to reduce chronic pain.
This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).
Chronic pain affects many spheres of the lives of affected individuals and those around them. In Canada, the prevalence of chronic pain is estimated at 15% of adults aged 18 and over. Among seniors, the prevalence of this health problem can reach up to 50% and affect one in two seniors. Chronic pain is one of the leading causes of work disability. In this context, pain reduction remains one of the most effective methods to enable the worker to stay at work. Considering the aging Quebec population, labor needs and the average retirement age which is increasingly postponed, it becomes crucial to take an interest in aging workers and their continued employment.
Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation method that has shown promise in reducing chronic pain. Recently, several research teams have shown that tDCS has beneficial effects on pain, physical function and social participation in seniors. Despite all these recent advances, very few studies have focused on optimizing tDCS treatment modalities and no studies have focused on the impact of tDCS on return to work or retention. The vast majority of studies using tDCS to reduce pain give one tDCS session per day for 5 consecutive days. This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
5 tDCS sessions in 1 week
Device: transcranial direct current stimulation
11 tDCS sessions devised in 4 weeks
Device: transcranial direct current stimulation
Anodal, 2mA, tDCS session applied on M1 for 20 minutes.
Pain intensity
0-10 Numerical rating scale
Time frame: Before tDCS
Pain intensity
0-10 Numerical rating scale
Time frame: 1 week
Pain intensity
0-10 Numerical rating scale
Time frame: 4 weeks
Pain intensity
0-10 Numerical rating scale
Time frame: 4 weeks after the last tDCS session
Disability
Pain Disability Index
Time frame: Before tDCS
Disability
Pain Disability Index
Time frame: 1 week
Disability
Pain Disability Index
Time frame: 4 weeks
Disability
Pain Disability Index
Time frame: 4 weeks after the last tDCS session
Work role functioning
Work Role Functioning Questionnaire
Time frame: Before tDCS
Work role functioning
Work Role Functioning Questionnaire
Time frame: 1 week
Work role functioning
Work Role Functioning Questionnaire
Time frame: 4 weeks
Work role functioning
Work Role Functioning Questionnaire
Time frame: 4 weeks after the last tDCS session
Physical Functioning
Brief Pain Inventory
Time frame: Before tDCS
Physical Functioning
Brief Pain Inventory
Time frame: 1 week
Physical Functioning
Brief Pain Inventory
Time frame: 4 weeks
Physical Functioning
Brief Pain Inventory
Time frame: 4 weeks after the last tDCS session
Anxiety
Beck anxiety inventory
Time frame: Before tDCS
Anxiety
Beck anxiety inventory
Time frame: 1 week
Anxiety
Beck anxiety inventory
Time frame: 4 weeks
Anxiety
Beck anxiety inventory
Time frame: 4 weeks after the last tDCS session
Depression
Beck depression inventory
Time frame: Before tDCS
Depression
Beck depression inventory
Time frame: 1 week
Depression
Beck depression inventory
Time frame: 4 weeks
Depression
Beck depression inventory
Time frame: 4 weeks after the last tDCS session
Impression of change
Patient Global impression of change
Time frame: 1 week
Impression of change
Patient Global impression of change
Time frame: 4 weeks
Impression of change
Patient Global impression of change
Time frame: 4 weeks after the last tDCS session
Central sensitization
central sensitization inventory
Time frame: Before tDCS
Central sensitization
central sensitization inventory
Time frame: 1 week
Central sensitization
central sensitization inventory
Time frame: 4 weeks
Central sensitization
central sensitization inventory
Time frame: 4 weeks after the last tDCS session
Recruitment
Feasibility of the study
Time frame: through study completion, about 2 years
Security
Feasibility of the study
Time frame: through study completion, about 2 years
Intervention
Feasibility of the study
Time frame: through study completion, about 2 years
Not enrolling at this site.
Plan to share: Yes — Upon request to the corresponding author
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Upon request
No publications or documents are linked to this record.
Started May 2022 (actual). Primary completion is estimated for Apr 2024, 23 months after the start.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 23 months is above that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.